Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow-Up Study [0.03%]
炎症性肠病焦虑和抑郁症状的持续性：一项纵向随访研究
Christy Riggott,Keeley M Fairbrass,Elspeth A Guthrie et al.
Christy Riggott et al.
Background: Poor psychological health affects many patients with inflammatory bowel disease (IBD), but the persistence of these symptoms is unclear. Metho...
Meta-Analysis: Immune-Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma [0.03%]
meta分析：免疫相关不良事件与肝细胞癌免疫检查点抑制剂改善疗效有关
Shijia Liu,Zhichao Li,Junlong Lin et al.
Shijia Liu et al.
Background: While immune-related adverse events (irAEs) have been linked to improved outcomes in melanoma and non-small cell lung cancer (NSCLC), their prognostic role in hepatocellular carcinoma (HCC), a malignancy arisi...
Clinical Trial: Simplified Bowel Preparation for Small Bowel Capsule Endoscopy in Crohn's Disease [0.03%]
简化的小肠胶囊内镜检查清洁日方案在克罗恩病中的临床研究
Raphaëlle Rouveyre,Sandrine Coudol,Michael Collins et al.
Raphaëlle Rouveyre et al.
Background: Small bowel (SB) capsule endoscopy (SBCE) is a key tool in patients with Crohn's disease (CD). Optimal bowel preparation remains debated. Aims...
Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome [0.03%]
利福昔明与低FODMAP饮食治疗肠易激综合征的临床试验
Kee Huat Chuah,Qing Yuan Loo,Audrey Joe Chii Loh et al.
Kee Huat Chuah et al.
Background: Rifaximin and the low FODMAP diet (LFD) are suggested as second-line therapies for irritable bowel syndrome (IBS). Direct comparative data are limited. ...
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases [0.03%]
炎症性肠病患者使用生物制剂和Janus激酶抑制剂的带状疱疹风险：总体及比较分析
Dhruv Ahuja,Soo-Kyung Park,Kuan-Hung Yeh et al.
Dhruv Ahuja et al.
Background: Advanced therapies increase the risk of shingles in inflammatory bowel diseases (IBD). Aim: To compare the risk of shingles...
Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease [0.03%]
轻度内镜下疾病活动与炎症性肠病老年患者的不良结局相关
Catherine Z Tang,Olivia R Delau,Seymour Katz et al.
Catherine Z Tang et al.
Background: The benefits of achieving endoscopic remission among older adults with inflammatory bowel disease (IBD) who have mild persistent disease activity are unknown. ...
Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific Mortality [0.03%]
代谢紊乱相关肝脂肪变性疾病的健康社会决定因素及全因/特定原因死亡率
Donghee Kim,Pojsakorn Danpanichkul,Karn Wijarnpreecha et al.
Donghee Kim et al.
Background: Social determinants of health (SDoH) are the preventable health inequities, and the associations between SDoH and health outcomes among individuals with metabolic dysfunction-associated steatotic liver disease...
Meta-Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea [0.03%]
系统评价和 meta 分析：胆汁酸腹泻使用吸附剂的有效性和安全性
Saam Dilmaghani,Joelle BouSaba,Camille Lupianez-Merly et al.
Saam Dilmaghani et al.
Background: Bile acid diarrhoea, a common cause of diarrhoea-predominant irritable bowel syndrome, has a similar prevalence to coeliac disease and inflammatory bowel diseases. The mainstay of treatment is bile acid seques...
Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker-Based Strategy [0.03%]
述评：基于生物标志物策略推进乙型肝炎肝细胞癌的筛查工作
Yu Jun Wong
Yu Jun Wong
Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker-Based Strategy-Authors' Reply [0.03%]
编者评论：采用生物标志物策略推进乙型肝炎肝细胞癌的筛查作者回应
Tanat Saeoui,Chayanis Kositamongkol,Pochamana Phisalprapa et al.
Tanat Saeoui et al.